The Immunology Podcast cover image

“AAI 2022: Treg Modulation” Featuring Dr. Alice Long

The Immunology Podcast

00:00

The Future of IL2 and T-Cell Exhaustion

The molecule itself IL2, unmutated is in later trials across autoimmune diseases. All of the different varieties of engineered IL2 molecules are on very much earlier trials many of them just in healthy controls. So do you think then we're looking at like five years until we start seeing IL2 being used in a context like this? Oh wow when I say being used that's a tricky term so in trials for sure type 1 diabetes is a hard bar but hopefully fingers crossed approving our first drug beyond insulin to treat type 1 diabetes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app